Astrazeneca Pharma India Ltd vs Bdh Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 12, 2026

Key Highlights

The Latest Trading Price of Astrazeneca Pharma India Ltd is ₹ 8308 as of 12 May 15:30 . The P/E Ratio of Astrazeneca Pharma India Ltd changed from 80.7 on March 2021 to 185.9 on March 2025 . This represents a CAGR of 18.16% over 5 yearsThe P/E Ratio of BDH Industries Ltd changed from 8.6 on March 2021 to 16.3 on March 2025 . This represents a CAGR of 13.64% over 5 years The Market Cap of Astrazeneca Pharma India Ltd changed from ₹ 7525 crore on March 2021 to ₹ 21515 crore on March 2025 . This represents a CAGR of 23.38% over 5 yearsThe Market Cap of BDH Industries Ltd changed from ₹ 53.19 crore on March 2021 to ₹ 151.46 crore on March 2025 . This represents a CAGR of 23.28% over 5 years The revenue of Astrazeneca Pharma India Ltd for the Dec '25 is ₹ 618.18 crore as compare to the Sep '25 revenue of ₹ 565.26 crore. This represent the growth of 9.36% The revenue of BDH Industries Ltd for the Dec '25 is ₹ 29.87 crore as compare to the Sep '25 revenue of ₹ 19.51 crore. This represent the growth of 53.1% The ebitda of Astrazeneca Pharma India Ltd for the Dec '25 is ₹ 51.44 crore as compare to the Sep '25 ebitda of ₹ 76.06 crore. This represent the decline of -32.37% The ebitda of BDH Industries Ltd for the Dec '25 is ₹ 4.76 crore as compare to the Sep '25 ebitda of ₹ 3.88 crore. This represent the growth of 22.68% The net profit of Astrazeneca Pharma India Ltd changed from ₹ -11.79 crore to ₹ 32.59 crore over 7 quarters. This represents a CAGR of NaN% The net profit of BDH Industries Ltd changed from ₹ 1.57 crore to ₹ 3.49 crore over 7 quarters. This represents a CAGR of 57.85% The Dividend Payout of Astrazeneca Pharma India Ltd changed from 5.36 % on March 2021 to 69.12 % on March 2025 . This represents a CAGR of 66.76% over 5 yearsThe Dividend Payout of BDH Industries Ltd changed from 28.02 % on March 2021 to 27.96 % on March 2025 . This represents a CAGR of -0.04% over 5 years .

About Astrazeneca Pharma India Ltd

AstraZeneca Pharma India Limited (APIL) was incorporated on July 11, 1979.
The Company is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and co-ordinates clinical trial services with an overseas group company.
The major therapy areas where the company operates are Onocology, Alimentary & Metabolism, Cardio Vascular, Renal, Diabetes, Respiratory and Oncology. AstraZeneca Pharma India, formerly known as Astra-IDL (AIL), was an erstwhile joint venture of Astra Zeneca, UK and Hinduja controlled IDL. Astra Pharmaceuticals AB, Sweden acquired all of the 1287500 equity shares in the Company of IDL, representing 25.75% of the Company's issued and paid up equity share capital.
Consequently, the Company became a subsidiary of Astra, which is a direct wholly owned subsidiary of Astra AB, Sweden (now known as AstraZeneca Pharmaceuticals AB Sweden) and an indirect wholly owned subsidiary of AstraZeneca Plc, the Group parent Company.

About BDH Industries Ltd

Incorporated in 1990 as a private limited company, BDH Industries Limited (BDHIL) was converted into a public limited company in 1994.
It was established to takeover a going concern, Bombay Drug House Pvt Ltd. This company was amalgamated with BDHIL in 1994 and, since then, it has been manufacturing a wide range of drug formulations in the antibiotic, anti-inflamatory and anti-microbial segments. The Company is engaged in manufacturing of therapeutic formulations covering wide range of Pharmaceuticals and Renewable Energy segments.
BDH offers a full range of Oral Solid Dosages (OSD) technologies.
Research &Development Centre at Kandivali, Mumbai, undertake formulation development projects on new Novel Drug Delivery System (NDDS). It came out with a public issue in Feb.'95, aggregating Rs 6.

FAQs for the comparison of Astrazeneca Pharma India Ltd and BDH Industries Ltd

Which company has a larger market capitalization, Astrazeneca Pharma India Ltd or BDH Industries Ltd?

Market cap of Astrazeneca Pharma India Ltd is 20,770 Cr while Market cap of BDH Industries Ltd is 214 Cr

What are the key factors driving the stock performance of Astrazeneca Pharma India Ltd and BDH Industries Ltd?

The stock performance of Astrazeneca Pharma India Ltd and BDH Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Astrazeneca Pharma India Ltd and BDH Industries Ltd?

As of May 12, 2026, the Astrazeneca Pharma India Ltd stock price is INR ₹8308.3. On the other hand, BDH Industries Ltd stock price is INR ₹372.75.

How do dividend payouts of Astrazeneca Pharma India Ltd and BDH Industries Ltd compare?

To compare the dividend payouts of Astrazeneca Pharma India Ltd and BDH Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.